ClinicalTrials.gov
ClinicalTrials.gov Menu

Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency (SIRENA-II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01223755
Recruitment Status : Terminated (safety and efficacy reason)
First Posted : October 19, 2010
Last Update Posted : February 25, 2013
Sponsor:
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research